| NDC Code | 72426-818-03 |
|---|
| Package Description | 30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (72426-818-03) |
|---|
| Product NDC | 72426-818 |
|---|
| Product Type Name | HUMAN PRESCRIPTION DRUG |
|---|
| Proprietary Name | Nexlizet |
|---|
| Non-Proprietary Name | Bempedoic Acid And Ezetimibe |
|---|
| Dosage Form | TABLET, FILM COATED |
|---|
| Usage | ORAL |
|---|
| Start Marketing Date | 20200309 |
|---|
| Marketing Category Name | NDA |
|---|
| Application Number | NDA211617 |
|---|
| Manufacturer | Esperion Therapeutics, Inc. |
|---|
| Substance Name | BEMPEDOIC ACID; EZETIMIBE |
|---|
| Strength | 180; 10 |
|---|
| Strength Unit | mg/1; mg/1 |
|---|
| Pharmacy Classes | Adenosine Triphosphate-Citrate Lyase Inhibitor [EPC], Adenosine Triphosphate-Citrate Lyase Inhibitors [MoA], Decreased Cholesterol Absorption [PE], Dietary Cholesterol Absorption Inhibitor [EPC] |
|---|